View in EDS HTML Full Text PDF Full Text

Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification.

Saved in:
Bibliographic Details
Title: Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification.
Authors: Pokorna S; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.; J.Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences, Prague, Czech Republic., Khersonsky O; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Lipsh-Sokolik R; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Goldenzweig A; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Nielsen R; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Ashani Y; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Peleg Y; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Unger T; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Albeck S; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Dym O; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Tirosh A; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Tarayra R; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel., Hocquemiller M; Lysogene, Neuilly-sur-Seine, France., Laufer R; Lysogene, Neuilly-sur-Seine, France., Ben-Dor S; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel., Silman I; Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel., Sussman JL; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel., Fleishman SJ; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel., Futerman AH; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Source: The FEBS journal [FEBS J] 2023 Jul; Vol. 290 (13), pp. 3383-3399. Date of Electronic Publication: 2023 Mar 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36808692
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pokorna+S%22">Pokorna S</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.; J.Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences, Prague, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Khersonsky+O%22">Khersonsky O</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Lipsh-Sokolik+R%22">Lipsh-Sokolik R</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Goldenzweig+A%22">Goldenzweig A</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Nielsen+R%22">Nielsen R</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Ashani+Y%22">Ashani Y</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Peleg+Y%22">Peleg Y</searchLink>; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Unger+T%22">Unger T</searchLink>; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Albeck+S%22">Albeck S</searchLink>; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Dym+O%22">Dym O</searchLink>; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Tirosh+A%22">Tirosh A</searchLink>; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Tarayra+R%22">Tarayra R</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Hocquemiller+M%22">Hocquemiller M</searchLink>; Lysogene, Neuilly-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Laufer+R%22">Laufer R</searchLink>; Lysogene, Neuilly-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Ben-Dor+S%22">Ben-Dor S</searchLink>; Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Silman+I%22">Silman I</searchLink>; Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Sussman+JL%22">Sussman JL</searchLink>; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Fleishman+SJ%22">Fleishman SJ</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.<br /><searchLink fieldCode="AU" term="%22Futerman+AH%22">Futerman AH</searchLink>; Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101229646%22">The FEBS journal</searchLink> [FEBS J] 2023 Jul; Vol. 290 (13), pp. 3383-3399. <i>Date of Electronic Publication: </i>2023 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Blackwell+Pub%2E+on+behalf+of+the+Federation+of+European+Biochemical+Societies%22">Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101229646 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1742-4658 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221742464X%22">1742464X </searchLink><i>NLM ISO Abbreviation: </i>FEBS J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36808692
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/febs.16758
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3383
    Titles:
      – TitleFull: Design of a stable human acid-β-glucosidase: towards improved Gaucher disease therapy and mutation classification.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pokorna S
      – PersonEntity:
          Name:
            NameFull: Khersonsky O
      – PersonEntity:
          Name:
            NameFull: Lipsh-Sokolik R
      – PersonEntity:
          Name:
            NameFull: Goldenzweig A
      – PersonEntity:
          Name:
            NameFull: Nielsen R
      – PersonEntity:
          Name:
            NameFull: Ashani Y
      – PersonEntity:
          Name:
            NameFull: Peleg Y
      – PersonEntity:
          Name:
            NameFull: Unger T
      – PersonEntity:
          Name:
            NameFull: Albeck S
      – PersonEntity:
          Name:
            NameFull: Dym O
      – PersonEntity:
          Name:
            NameFull: Tirosh A
      – PersonEntity:
          Name:
            NameFull: Tarayra R
      – PersonEntity:
          Name:
            NameFull: Hocquemiller M
      – PersonEntity:
          Name:
            NameFull: Laufer R
      – PersonEntity:
          Name:
            NameFull: Ben-Dor S
      – PersonEntity:
          Name:
            NameFull: Silman I
      – PersonEntity:
          Name:
            NameFull: Sussman JL
      – PersonEntity:
          Name:
            NameFull: Fleishman SJ
      – PersonEntity:
          Name:
            NameFull: Futerman AH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1742-4658
          Numbering:
            – Type: volume
              Value: 290
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: The FEBS journal
              Type: main
ResultId 1